Cargando…

Treatment-emergent and trajectory-based peripheral gene expression markers of antidepressant response

Identifying biomarkers of antidepressant response may advance personalized treatment of major depressive disorder (MDD). We aimed to identify longitudinal changes in gene expression associated with response to antidepressants in a sample of MDD patients treated with escitalopram. Patients (N = 153)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fiori, Laura M., Orri, Massimiliano, Aouabed, Zahia, Théroux, Jean François, Lin, Rixing, Nagy, Corina, Frey, Benicio N., Lam, Raymond W., MacQueen, Glenda M., Milev, Roumen, Müller, Daniel J., Parikh, Sagar V., Rotzinger, Susan, Uher, Rudolf, Foster, Jane A., Kennedy, Sidney H., Turecki, Gustavo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380246/ https://www.ncbi.nlm.nih.gov/pubmed/34420030 http://dx.doi.org/10.1038/s41398-021-01564-8

Ejemplares similares

Integrated genome-wide methylation and expression analyses reveal functional predictors of response to antidepressants
por: Ju, Chelsey, et al.
Publicado: (2019)

Metabolomic signatures associated with depression and predictors of antidepressant response in humans: A CAN-BIND-1 report
por: Caspani, Giorgia, et al.
Publicado: (2021)

SNORD90 induces glutamatergic signaling following treatment with monoaminergic antidepressants
por: Lin, Rixing, et al.
Publicado: (2023)

Developing an Electroencephalography-Based Model for Predicting Response to Antidepressant Medication
por: Schwartzmann, Benjamin, et al.
Publicado: (2023)

Association between the expression of lncRNA BASP-AS1 and volume of right hippocampal tail moderated by episode duration in major depressive disorder: a CAN-BIND 1 report
por: Yrondi, Antoine, et al.
Publicado: (2021)

Association Between Side Effects and Blood microRNA Expression Levels and Their Targeted Pathways in Patients With Major Depressive Disorder Treated by a Selective Serotonin Reuptake Inhibitor, Escitalopram: A CAN-BIND-1 Report
por: Yrondi, Antoine, et al.
Publicado: (2019)

The Differential Relation of Emotional, Physical, and Sexual Abuse Histories to Antidepressant Treatment Remission and Persistence of Anhedonia in Major Depression: A CAN-BIND-1 Report
por: Harkness, Kate L., et al.
Publicado: (2023)

MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genes
por: Lopez, Juan Pablo, et al.
Publicado: (2017)

Replication of machine learning methods to predict treatment outcome with antidepressant medications in patients with major depressive disorder from STAR*D and CAN-BIND-1
por: Nunez, John-Jose, et al.
Publicado: (2021)

Prediction of depression treatment outcome from multimodal data: a CAN-BIND-1 report
por: Sajjadian, Mehri, et al.
Publicado: (2023)

An investigation of cortical thickness and antidepressant response in major depressive disorder: A CAN-BIND study report
por: Suh, Jee Su, et al.
Publicado: (2020)

Predicting escitalopram treatment response from pre-treatment and early response resting state fMRI in a multi-site sample: A CAN-BIND-1 report
por: Harris, Jacqueline K., et al.
Publicado: (2022)

GPR56/ADGRG1 is associated with response to antidepressant treatment
por: Belzeaux, Raoul, et al.
Publicado: (2020)

Reliability of a functional magnetic resonance imaging task of emotional conflict in healthy participants
por: Hassel, Stefanie, et al.
Publicado: (2019)

Exploring brain connectivity changes in major depressive disorder using functional‐structural data fusion: A CAN‐BIND‐1 study
por: Ayyash, Sondos, et al.
Publicado: (2021)

Effects of CYP2C19 and CYP2D6 gene variants on escitalopram and aripiprazole treatment outcome and serum levels: results from the CAN-BIND 1 study
por: Islam, Farhana, et al.
Publicado: (2022)

Pretreatment anxious depression as a predictor of side effect frequency and severity in escitalopram and aripiprazole adjunctive therapy
por: Espinola, Caroline W., et al.
Publicado: (2022)

Genome-wide analysis suggests the importance of vascular processes and neuroinflammation in late-life antidepressant response
por: Marshe, Victoria S., et al.
Publicado: (2021)

A standardized workflow for long-term longitudinal actigraphy data processing using one year of continuous actigraphy from the CAN-BIND Wellness Monitoring Study
por: Slyepchenko, Anastasiya, et al.
Publicado: (2023)

Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort
por: Lam, Raymond W., et al.
Publicado: (2016)

“One Degree of Separation”: A Mixed-Methods Evaluation of Canadian Mental Health Care User and Provider Experiences With Remote Care During COVID-19
por: Ceniti, Amanda K., et al.
Publicado: (2022)

Resting-state EEG delta and alpha power predict response to cognitive behavioral therapy in depression: a Canadian biomarker integration network for depression study
por: Schwartzmann, Benjamin, et al.
Publicado: (2023)

Multi-omic modeling of antidepressant response implicates dynamic immune and inflammatory changes in individuals who respond to treatment
por: Fuh, Shih-Chieh, et al.
Publicado: (2023)

Cell type specific transcriptomic differences in depression show similar patterns between males and females but implicate distinct cell types and genes
por: Maitra, Malosree, et al.
Publicado: (2023)

Accelerated brain aging in major depressive disorder and antidepressant treatment response: A CAN-BIND report
por: Ballester, Pedro L., et al.
Publicado: (2021)

Investigation of miR-1202, miR-135a, and miR-16 in Major Depressive Disorder and Antidepressant Response
por: Fiori, Laura M, et al.
Publicado: (2017)

Multisite Comparison of MRI Defacing Software Across Multiple Cohorts
por: Theyers, Athena E., et al.
Publicado: (2021)

Magnetic Resonance Imaging Sequence Identification Using a Metadata Learning Approach
por: Liang, Shuai, et al.
Publicado: (2021)

Functional Recovery in Major Depressive Disorder: Providing Early Optimal Treatment for the Individual Patient
por: Oluboka, Oloruntoba J, et al.
Publicado: (2017)

Cocaine-related DNA methylation in caudate neurons alters 3D chromatin structure of the IRXA gene cluster.
por: Vaillancourt, Kathryn, et al.
Publicado: (2020)

Use of Machine Learning for Predicting Escitalopram Treatment Outcome From Electroencephalography Recordings in Adult Patients With Depression
por: Zhdanov, Andrey, et al.
Publicado: (2020)

Pro-inflammatory markers predict response to sequential pharmacotherapy in major depressive disorder: a CAN-BIND-1 report
por: Husain, M. I., et al.
Publicado: (2023)

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder
por: Yatham, Lakshmi N, et al.
Publicado: (2018)

A postmenopausal woman presenting with Ekbom syndrome associated with recurrent depressive disorder: a case report
por: Mahler, Courtney, et al.
Publicado: (2008)

Psychological Factors in Asthma
por: Van Lieshout, Ryan J, et al.
Publicado: (2008)

The Role of Adipokines in Understanding the Associations between Obesity and Depression
por: Taylor, Valerie H., et al.
Publicado: (2010)

Brazilian research on child and adolescent suicide: looking at the past to plan the future
por: Orri, Massimiliano, et al.
Publicado: (2020)

Common Data Elements to Facilitate Sharing and Re-use of Participant-Level Data: Assessment of Psychiatric Comorbidity Across Brain Disorders
por: Vaccarino, Anthony L., et al.
Publicado: (2022)

Response of Depression to Botulinum Toxin Treatment: Agitation as a Predictor
por: Milev, Roumen
Publicado: (2015)

Integrative DNA Methylation and Gene Expression Analysis in the Prefrontal Cortex of Mexicans Who Died by Suicide
por: Romero-Pimentel, Ana L, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_an1330q81ch31t81hv3suus1pd